NASDAQ Composite ended the session with Seattle Genetics jumping 5.07% to $184.78 on Friday, after two consecutive sessions in a row of losses. NASDAQ Composite dropped 0.65% to $13,027.06, following last session’s downward trend on what was a somewhat rough trend exchanging session today.
Seattle Genetics today’s close was $184.78, 15.78% below its 52-week high of $213.94.
Seattle Genetics’s Sales
Seattle Genetics’s sales growth is 101.2% for the ongoing quarter and 60.8% for the next. The company’s growth estimates for the ongoing quarter and the next is 521.4% and 72.4%, respectively.
Seattle Genetics’s Revenue
Year-on-year quarterly revenue growth grew by 397.9%, now sitting on 1.86B for the twelve trailing months.
Seattle Genetics’s last day, last week, and last month’s average volatility was a negative 0.47%, a negative 0.06%, and a negative 0.46%, respectively.
Seattle Genetics’s last day, last week, and last month’s high and low average amplitude percentage was 1.86%, 2.44%, and 2.98%, respectively.
Seattle Genetics’s Stock Yearly Top and Bottom Value
Seattle Genetics’s stock is valued at $184.78 at 16:25 EST, way below its 52-week high of $213.94 and way above its 52-week low of $90.57.
Seattle Genetics’s Moving Average
Seattle Genetics’s value is above its 50-day moving average of $183.03 and above its 200-day moving average of $176.63.